News

DelveInsight's CD40/CD40L Inhibitors Market Size, Target Population, Competitive Landscape & Market Forecast report includes a ...
One of the main factors determining therapeutic antibodies’ half-life is the interaction between the antibody’s Fc region and ...
Annexon has completed enrollment in its phase 3 ARCHER II trial of vonaprument (formerly ANX007) for dry age-related macular ...
The drug is indicated for the treatment rheumatoid arthritis, polyarticular juvenile idiopathic arthritis, psoriatic ...
Measles is one of 100 viruses that the team at VUMC is systematically making antibodies for by using single-cell sequencing — ...
A new study done by scientists in Switzerland and Sweden investigated the use of automated systems to develop multispecific ...
Zentiva Group has entered a licence and supply agreement with Lupin for the commercialisation of latter’s biosimilar Certolizumab Pegol.
Pharma major Lupin has signed a USD 50 million agreement with a European pharmaceutical company. Lupin has entered into a license and supply agreement to commercialize its biosimilar Certolizumab ...
Fab operations have wrestled with big data management issues for decades. Standards help, but only if sufficient attention to detail is taken during collection. Semiconductor wafer manufaFcturing ...
Horseradish peroxidase or biotin-conjugated secondary antibodies and a Tyramide signal amplification kit (PerkinElmer) were used after incubating the primary antibodies. For primary antibodies of ...
3.3 Trifunctional antibody (Fab)-fusion proteins combining RD_IL-15 with IL-21 To validate the concept and further improve the molecular design, we generated another novel trifunctional ...
Fab launches spring sale and showcases latest product improvements Fab is Epic's unified content marketplace to buy, sell and share digital assets.